Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost

Intensive Care Medicine

Volumn 24, Issue 6, 1998, Pages 631-634

  Olschewski, H ^a   Ghofrani, H A ^a   Walmrath, D ^a   Temmesfeld Wollbruck B ^a   Grimminger, F ^a   Seeger, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Inhaled iloprost; Low output failure; Primary pulmonary hypertension; Prostacyclin; Pulmonary selective vasodilatation; Right heart decompensation

Indexed keywords

ILOPROST; NITRIC OXIDE; PROSTACYCLIN; VASODILATOR AGENT;

ADULT; AEROSOL; ARTERIAL PRESSURE; ARTICLE; CASE REPORT; FEMALE; GAS EXCHANGE; HEART FAILURE; HEART INDEX; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG INFILTRATE; LUNG VASCULAR RESISTANCE; PULMONARY HYPERTENSION; SHOCK; SIDE EFFECT; VASODILATATION;

EID: 0031927873     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050628     Document Type: Article

References (10)

1. D'Alonzo GE, Barst RJ, Ayres SM, et al. (1991) Survival in patients with primary pulmonary hypertension: results from a National Prospective Registry. Ann Intern Med 115: 343-349
2. Higenbottam TW, Spiegelhalter D, Scott JP, Fuster V, Dinh-Xuan AT, Caine N, Wallwork J (1993) Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J 70: 366-370
3. Barst RJ, Rubin LJ, Long WA, et al. (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334: 296-301
4. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet 342: 961-962
5. Olschewski H, Walmrath D, Schermuly R, et al. (1996) Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 124: 820-824
6. Barst RJ, Rubin LJ, McGoon MD, et al (1994) Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 121:409-415
7. Warren JB, Higenbottam T (1996) Caution with the use of inhaled nitric oxide. Lancet 348: 629-630
8. Miller O, Tang S, Keech A, Celermajer D (1995) Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346: 51-52
9. Walmrath D, Schneider T, Schermuly R, Olschewski H, Grimminger F, Seeger W (1996) Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 153: 991-996
10. Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W (1995) Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis. Am J Respir Crit Care Med 151: 724-730